OrgUnit's Researchers
(Persons)

Results 1-5 of 24 (Search time: 0.002 seconds).

FullnameTranslated NameEmail
Agarwal, RishuRishu.AGARWAL@austin.org.au
Baker, AmyAmy.BAKER@austin.org.au
Bennett, AshwiniAshwini.BENNETT@austin.org.au
Berlangieri, Salvatore USam.Berlangieri@austin.org.au
Chua, Chong Chynchyn.chua2@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 201-220 of 305 (Search time: 0.011 seconds).

Publication YearTitleAuthor(s)
2011-Apr-2004A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer.Mitchell, Paul L R ; Basser, R L; Chipman, M; Grigg, Andrew P ; Mansfield, R; Cebon, Jonathan S ; Davis, Ian D; Appia, F; Green, M
2021-May-2008A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.Mitchell, Paul L R ; Marlton, Paula; Grigg, Andrew P ; Seymour, John F; Hertzberg, Mark; Enno, Arno; Herrmann, Richard; Bond, Rodney; Arthur, Chris
203Oct-2023Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes.Mo, Allison ; Wood, Erica; Shortt, Jake; Hu, Erin; McQuilten, Zoe
204Nov-2023Pneumorrhachis secondary to exacerbation of asthma: A case report and literature reviewZhao, Chris Zi-Fan; Poci, Nadia; Niewodowski, Daniel; Baker, Amy ; McDonald, Christine F 
205Jul-2019Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory Response.Hamadi, Abdullah; Grigg, Andrew P ; Dobie, Gasim; Burbury, Kate L; Schwarer, Anthony P ; Kwa, Faith A; Jackson, Denise E
2061-Oct-2002Positron emission tomography and epilepsy.Casse, Rey; Rowe, Christopher C ; Newton, Mark R; Berlangieri, Salvatore U ; Scott, Andrew M 
2071-Jul-2004Positron emission tomography scanning in the assessment of patients with lymphoma.Foo, S S; Mitchell, Paul L R ; Berlangieri, Salvatore U ; Smith, C L; Scott, Andrew M 
2085-May-2005Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.Yap, Kelvin K; Byrne, Amanda J; Berlangieri, Salvatore U ; Poon, Aurora M T ; Mitchell, Paul L R ; Knight, Simon R ; Clarke, Peter C; Harris, Anthony H; Tauro, Andrew; Rowe, Christopher C ; Scott, Andrew M 
209Feb-2021Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.Bhurani, Mansi; Admojo, Lorenz; Van Der Weyden, Carrie; Twigger, Robert; Bazargan, Ali; Quach, Hang; Zimet, Allan; Coyle, Luke; Lindsay, Julian; Radeski, Dejan; Hawkes, Eliza A ; Kennedy, Glen; Irving, Ian; Gutta, Naadir; Trotman, Judith; Yeung, James; Dunlop, Lindsay; Hua, Minh; Giri, Pratyush; Yuen, Sam; Panicker, Shyam; Moreton, Susan; Khoo, Liane; Scott, Ashleigh; Kipp, David; McQuillan, Andrew; McCormack, Chris; Dickinson, Michael; Prince, Henry Miles
2108-Jul-2021Predicting primary treatment failure using interim FDG-PET scanning in Diffuse large B-cell lymphoma.Wight, Joel C ; Wai, Shin Hnin; Shen, Edward; Lee, Sze Ting ; Berlangieri, Salvatore U ; Fancourt, Tineke ; Hawkes, Eliza A ; Hannah, Anthony; Leung, Teresa; Chong, Geoffrey 
21111-Sep-2012Predicting the diagnosis of autism spectrum disorder using gene pathway analysis.Skafidas, E; Testa, R; Zantomio, D ; Chana, Gursharan; Everall, I P; Pantelis, C
212Jun-2023Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft-versus-host disease prophylaxis following allogeneic haemopoietic cell transplantation.Ramanan, Radha; Lim, Andrew Boon Ming ; Tan, Joanne L C; Barmanray, Rahul D; Mason, Kate; Collins, Jenny; Hillman, Matthew; Szer, Jeff; Bajel, Ashish; Ritchie, David
21328-Dec-2016Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)Rummel, M; Kim, TM; Aversa, F; Brugger, W; Capochiani, E; Plenteda, C; Re, F; Trask, P; Osborne, S; Smith, R ; Grigg, Andrew P 
2144-Sep-2017Prevalence and causes of preoperative anaemia in elective major surgery patientsHong, Frank S; Sieradzki, Nicole; Pollock, Claire; Nasra, Faye; Mo, Allison ; Willcox, Abbey ; Churilov, Leonid ; Ho, Wai Khoon ; Smith, Carole
21521-May-2007Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.Lee, S T; Berlangieri, Salvatore U ; Poon, A M T; Mitchell, Paul L R ; Pathmaraj, K ; Tabone, K; Byrne, Amanda J; O'Keefe, Graeme J; Knight, Simon R ; Clarke, C Peter; Scott, Andrew M 
216Feb-2016Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.Doan, Tan N; Kirkpatrick, Carl M J; Walker, Patricia; Slavin, Monica A; Ananda-Rajah, Michelle R; Morrissey, C Orla; Urbancic, Karen F ; Grigg, Andrew P ; Spencer, Andrew; Szer, Jeffrey; Seymour, John F; Kong, David C M
21725-Dec-2020Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy.Straus, David; Collins, Graham; Walewski, Jan; Zinzani, Pier Luigi; Grigg, Andrew P ; Sureda, Anna; Illes, Arpad; Kim, Tae Min; Alekseev, Sergey; Specht, Lena; Buccheri, Valeria; Younes, Anas; Connors, Joseph; Forero-Torres, Andres; Fenton, Keenan; Gautam, Ashish; Purevjal, Indra; Liu, Rachael; Gallamini, Andrea
218Aug-2023The prognostic impact of t(11;14) in multiple myeloma: A real-world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR).Lim, Kenneth Jc; Wellard, Cameron; Talaulikar, Dipti; Tan, Joanne Lc; Loh, Joanna; Puvanakumar, Pratheepan; Kuzich, James A; Ho, Michelle; Murphy, Matthew; Zeglinas, Nicole; Low, Michael Sy; Routledge, David; Lim, Andrew Boon Ming ; Gibbs, Simon D; Quach, Hang; Morgan, Sue; Moore, Elizabeth; Ninkovic, Slavisa
219Mar-2021Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial.Gleeson, Mary; Counsell, Nicholas; Cunningham, David; Lawrie, Anthony; Clifton-Hadley, Laura; Hawkes, Eliza A ; McMillan, Andrew; Ardeshna, Kirit M; Burton, Cathy; Chadwick, Nick; Gambell, Joanna; Smith, Paul; Mouncey, Paul; Pocock, Christopher; Radford, John; Davies, John; Turner, Deborah; Kruger, Anton; Johnson, Peter; Linch, David
2202-May-2018Prognostic Markers in Core-Binding Factor AML and Improved Survival with Multiple Consolidation Cycles of Intermediate/High-dose Cytarabine.Prabahran, Ashvind; Tacey, Mark A ; Fleming, Shaun; Wei, Andrew; Tate, Courtney; Marlton, Paula; Wight, Joel C ; Grigg, Andrew P ; Tuckfield, Annabel; Szer, Jeff; Ritchie, David; Chee, Lynette